Immucell (ICCC) Share-based Compensation (2010 - 2026)
Immucell's (ICCC) quarterly Share-based Compensation came in at $239867.0 in Q2 2026, down 55.12% on a YoY basis from $534500.0 in Q2 2025, and up 131.13% quarter-over-quarter from $103781.0 in Q4 2025.
Powered by 
Analysis
Immucell (ICCC) Share-based Compensation (2010 - 2026) Analysis & Trends
Immucell (ICCC) has reported Share-based Compensation for 17 consecutive years, with $239867.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Share-based Compensation fell 55.12% year-over-year to $239867.0; the trailing twelve-month figure through Jun 2026 stood at $513170.0 (down 3.99% YoY), and the FY2025 full-year result was $875883.0, up 31.91% from the prior year.
- Share-based Compensation improved to $239867.0 in Q2 2026 per ICCC's latest filing, from $103781.0 in the prior quarter.
- Across five years, Share-based Compensation topped out at $717859.0 in Q3 2025 and bottomed at $68863.0 in Q4 2024.
- Historically, Share-based Compensation has averaged $380876.8 across 5 years, with a median of $418750.0 in 2023.
- The sharpest annual moves came in 2022 and 2026: Share-based Compensation soared 190.83% in 2022, then sank 55.12% in 2026.
- Over 5 years, Share-based Compensation stood at $358500.0 in 2022, then tumbled by 71.92% to $100659.0 in 2023, then slumped by 31.59% to $68863.0 in 2024, then soared by 50.71% to $103781.0 in 2025, then soared by 131.13% to $239867.0 in 2026.
- According to Business Quant data, Share-based Compensation over the past three periods registered $239867.0, $103781.0, and $717859.0 for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.57 Bn | 40.38 Bn | 779.09 Mn | 16.09 Mn |
| 2 | Zoetis | 30.57 Bn | 28.90 Bn | 1.05 Bn | 92.00 Mn |
| 3 | Elanco Animal Health | 11.47 Bn | 10.94 Bn | 798.00 Mn | 7.00 Mn |
| 4 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 134.40 Mn | 413,000.00 |
| 5 | Immucell | 87.38 Mn | 78.52 Mn | 2.44 Mn | 239,867.00 |
| 6 | Zhengye Biotechnology Holding | 64.40 Mn | 57.30 Mn | - | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 239,867.00 |
| Dec 31, 2025 | 103,781.00 |
| Sep 30, 2025 | 717,859.00 |
| Jun 30, 2025 | 534,500.00 |
| Mar 31, 2025 | 457,500.00 |
| Dec 31, 2024 | 68,863.00 |
| Sep 30, 2024 | 477,500.00 |
| Jun 30, 2024 | 431,500.00 |
| Mar 31, 2024 | 413,000.00 |
| Dec 31, 2023 | 100,659.00 |
| Sep 30, 2023 | 416,000.00 |
| Jun 30, 2023 | 421,500.00 |
| Mar 31, 2023 | 423,500.00 |
| Sep 30, 2022 | 358,500.00 |
| Jun 30, 2022 | 650,000.00 |
| Mar 31, 2022 | 279,500.00 |
| Dec 31, 2021 | 40,931.00 |
| Sep 30, 2021 | 228,500.00 |
| Jun 30, 2021 | 223,500.00 |
| Mar 31, 2021 | 228,500.00 |